2
Total investments
0
Early stage
0
Mid stage
0
Late stage
2y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Lead Investor
2024
At Remedly, we are future-proofing the healthcare industry with innovative cloud-based software solutions that use automation to streamline workflows and improve patient care.
Remedly has all of the software your practice needs in one turnkey solution. Tackle scheduling, invoicing, electronic medical records, marketing, inventory management, and more – all in one system. Future-proof your practice with a cloud-based software solution that uses automation to streamline workflows and improve patient care.
Remedlys HIPAA-compliant software includes: EHR, Practice Management, Patient Portal, Revenue Cycle Management, Analytics & Reports, eCommerce, Marketing.
Experience · 4 entries
All (4)
Investments (2)
Founder (1)
2024
Founder
Jan 2024
NEER is a tool designed to bring people together and foster connection - developed in response to Covid-19 pandemic and #MeToo Movement. Our app recognized a growing need: people struggle to approach one another, to be open, to feel safe doing so — and above all to take a risk.
And let’s be honest, we’re all a bit tired of endless swiping and being forced into a scenario that isn’t as casual as it should be. And studies show people are fed up with it. Humans simply want to meet, be together, and then maybe something will come of it — even if it’s just a friendship.
In partnering with local brands & businesses, creating a rewards system, and matchmaking based on intentions & interests, NEER is here to help you create genuine connections and get back out there — and safely at that.
Join the waitlist to become a member here: https://neerglobal.typeform.com/to/QarN3r1e?typeform-source=www.neer-global.com
Lead Investor
2024
At Remedly, we are future-proofing the healthcare industry with innovative cloud-based software solutions that use automation to streamline workflows and improve patient care.
Remedly has all of the software your practice needs in one turnkey solution. Tackle scheduling, invoicing, electronic medical records, marketing, inventory management, and more – all in one system. Future-proof your practice with a cloud-based software solution that uses automation to streamline workflows and improve patient care.
Remedlys HIPAA-compliant software includes: EHR, Practice Management, Patient Portal, Revenue Cycle Management, Analytics & Reports, eCommerce, Marketing.
Lead Investor
2024
Cytovale is a medical diagnostics company focused on providing a more rapid and insightful way to diagnose fast-moving and immune-mediated diseases. Our FDA cleared IntelliSep test is pioneering a new way of quickly and accurately analyzing white blood cells to stratify a patient’s risk of sepsis by performing a biomechanical evaluation of white blood cells collected from a standard blood draw in under 10 minutes.
Cytovale’s first market application will be for sepsis, one of the fastest-moving, most lethal conditions in the world. Sepsis, a dysregulated immune response to infection, is often difficult to quickly and accurately diagnose. Sepsis is the no. 1 cause of death in hospitals, taking the lives of 270,000 people every year in the U.S. – more than opioid overdoses, prostate cancer, and breast cancer combined. Mortality from sepsis increases as much as eight percent with every hour of delayed treatment, and as much as 80 percent of sepsis deaths could be prevented with rapid diagnosis and treatment, making early detection essential.
Cytovale aims to provide critical insight for early identification of patients at risk of having sepsis, in the time needed for it to be useful.
Follow us on Twitter: twitter.com/cytovale
Subscribe to our newsletter: http://eepurl.com/huCdiH
2009
Appointed Associate Professor in Paediatric Dentistry, Department of Paediatric Dentistry
2009
Founded in 1831, NYU is one of the world’s foremost research universities and is a member of the selective Association of American Universities. The first Global Network University, NYU has degree-granting university campuses in New York and Abu Dhabi, and has announced a third in Shanghai; has a dozen other global academic sites, including London, Paris, Florence, Tel Aviv, Buenos Aires, and Accra; and sends more students to study abroad than any other U.S. college or university. Through its numerous schools and colleges, NYU conducts research and provides education in the arts and sciences, law, medicine, business, dentistry, education, nursing, the cinematic and performing arts, music and studio arts, public administration, social work, and continuing and professional studies, among other areas.
